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clear, however, whether the latter asso-
ciations are independent of the main 
association of DRB1*07:01 or whether 
they are secondary and result from link-
age disequilibrium with this allele of 
DRB1. Nonetheless, it is worth noting 
that GWAS also revealed a second HLA 
susceptibility factor whose association 
appears to be independent of the major 
HLA class II association (Jin et al., 2010; 
Quan et al., 2010).
A next step will be to identify the 
self-antigen binding the DRB1*07:01 
molecule, leading to autoimmune 
destruction of melanocytes. GWAS 
has revealed associations with alleles 
of tyrosinase (TYR), which encodes 
the protein that catalyzes melanin 
biosynthesis (Jin et al., 2010), and this 
might be considered a vitiligo antigen. 
Other proposed prime targets of the 
immune response in vitiligo include 
human melanoma antigen recognized 
by T-cells (MART-1), gp100/the silver 
homolog (SILV), tyrosinase-related 
protein 1 precursor (TYRP1), and 
tyrosinase-related-protein-2 (TYRP2) 
(Le Poole and Luiten, 2008).
The identification of HLA factors, 
whose role in antigen presentation is 
central and clear in the association of 
immune responses with susceptibility 
to vitiligo, allows one to postulate an 
autoimmune phenomenon in the cause 
of this disease. Improved understanding 
of its altered pathway is one more step 
toward the development of specific and 
efficient therapies for this devastating 
disease.
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Control of Central and Peripheral 
Tolerance to Melanocyte 
Differentiation Antigens by GILT
Jürgen C. Becker1 and David Schrama1
The strict control of the T-cell receptor repertoire is essential for prevention of 
autoimmune diseases. The repertoire of T cells is primarily formed in the thymus 
through positive and negative selection. The risk of an incomplete remov-
al of autoreactive T cells necessitates additional means to maintain peripheral 
tolerance. There is increasing evidence that the interferon (IfN)-γ-inducible 
lysosomal thiol reductase (GILT) allows peripheral tolerance to a melanocyte 
differentiation antigen by induction of specific regulatory T cells.
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2006). The ability of T cells to recognize 
a wide variety of foreign antigens is a 
result of random recombination events 
that generate T-cell receptors (TCR). 
However, because of the stochastic 
assembly of the TCR, T cells are likely 
to recognize both self- and foreign anti-
gens. On the one hand, the wide range 
of foreign antigen specificities generated 
ensures a nearly unlimited potential 
to recognize pathogens; on the other 
hand, the production of self-reactive T 
cells can result in debilitating autoim-
munity. Thus, a strict quality control of 
developing T cells is essential to prevent 
autoimmune diseases. To this end, the 
repertoire of T cells is formed primarily 
in the thymus through positive and 
negative selection of developing thymo-
cytes (Derbinski and Kyewski, 2010). 
Central tolerance is established within 
the thymus by purging self-reactive 
thymo cytes, reducing the propensity 
for autoreactivity among mature T cells 
after they gain entry to the periphery.
The fact that the recognition of 
self-antigens not only is essential for 
thymocytes’ survival and lineage com-
mitment but also may induce cell death 
remains incompletely understood. 
Moreover, the possibility—or risk—
of incomplete removal of T cells with 
self-antigen specificity necessitates 
additional mechanisms to maintain 
peripheral tolerance, especially when 
central tolerance inductions fail 
(Metzger and Anderson, 2011). These 
include the additional mechanisms of 
clonal deletion of mature autoreactive 
T cells in the periphery and active 
suppression of their activation by 
regulatory T cells (Tregs).
In this issue, Rausch and Hastings 
report findings on the role of inter-
feron (IFN)-γ-inducible lysosomal 
thiol reductase (GILT) for CD4 T-cell 
tolerance to a melanocyte differentia-
tion antigen, adding substantially to our 
understanding of central and peripheral 
tolerance to self-antigens (Rausch and 
Hastings, 2012).
Antigen processing and presenta-
tion via the class II pathway (Figure 1) 
are important for successful CD4+ T-cell 
stimulation and the development of 
the CD4+ T-cell repertoire. It has been 
reported that intracellular proteases 
are regulated by GILT (Goldstein et 
al., 2008). Intracellular proteases such 
as cysteinyl and aspartyl cathepsins 
(e.g., Cat B, D, or S) are essential for 
the degradation of endogenous and 
exogenous antigens, and each performs 
an important role in the processing of 
peptides for presentation. Peptides can-
not be loaded into the class II binding 
groove until CLIP is removed by the 
nonclassic molecule HLA-DM; after 
subsequent insertion of a high-affin-
ity peptide, stable human leukocyte 
antigen class II–peptide complexes 
are presented on the cell surface for 
CD4+ T-cell recognition. Indeed, GILT 
colocalizes with Cat B and D, thereby 
indicating that GILT is crucial for anti-
gen processing and presentation via 
the class II pathway (Goldstein et al., 
2008). Moreover, the reduction of 
disulfides is important in the processing 
of tumor antigens such as tyrosinase-
related protein 1 (TRP-1), tyrosinase, 
gp-100, Mart-1, and NY-ESO-1, all of 
which contain large numbers of cys-
teine residues (Rausch et al., 2010).
Based on this role of GILT for antigen 
processing and presentation and the 
relevance of MHC class II–restricted 
antigen presentation for the develop-
ment of the T-cell repertoire, Rausch 
and Hastings (2012) hypothesized that 
GILT has the potential to shape CD4+ 
T-cell tolerance to self-antigens. To test 
this hypothesis, they took advantage 
of a class II–restricted TRP1-specific 
TCR transgenic RAG1−/− mouse strain 
that was crossed with GILT−/− or white-
based brown (TRP1Bw) mice; the latter 
contains a radiation-induced inver-
sion interrupting the gene encoding 
TRP1 (Muranski et al., 2008). These 
experiments revealed an additional 
role for GILT in the maintenance of 
tolerance to TRP1. As expected, TRP1-
specific thymocytes were deleted 
Figure 1. effect of GILt on central and peripheral tolerance control. In Trp1 transgenic mice, 
Trp1-specific T cells are probably rescued by endogenous T-cell receptors from thymic depletion. 
Consequently, those Vb14Vα3.2 can be detected in the periphery and cause vitiligo. In the absence of 
IFN-γ–inducible lysosomal thiol reductase (GILT), vitiligo is delayed even though more transgenic T cells 
are present in the periphery. In RAG−/− Trp1 transgenic mice, the thymus lacks CD4 single-positive cells 
almost completely; consequently, transgenic T cells are hardly present in the periphery, and these mice 
do not develop vitiligo. In the absence of GILT, however, the mice do have both CD4 single-positive 
cells in the thymus and transgenic T cells in the periphery. The latter display partially the CD44+CD62l− 
effector memory phenotype. Mice not expressing Trp1 (Ag−/−) similarly escape negative selection in the 
thymus and have even larger number of transgenic T cells in the periphery, but these are largely of a 
naive phenotype. In addition, the frequency of regulatory T cells (CD4+Vb14+Foxp3+CD25+) is fourfold 
greater in GILT−/− mice compared with that observed in Ag−/− mice. Upon adoptive transfer of CD4+ cells, 
only those obtained from the Ag−/− mice cause vitiligo in the recipient animals. However, transfer of only 
CD4+CD25− cells from the GILT−/− mice causes mild vitiligo.
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centrally in the presence of GILT and 
TRP1. By contrast, CD4 single-positive 
thymocytes and peripheral T cells 
developed in the absence of GILT or 
TRP1 antigen, demonstrating that GILT 
is required for negative selection of 
TRP1–specific thymocytes. Surprisingly, 
however, neither GILT-expressing nor 
GILT−/− TRP1-specific TCR transgenic 
mice developed vitiligo.
Thus, although TRP1-specific T cells 
escape thymic deletion in the absence 
of GILT, they are nevertheless toler-
ant to TRP1, suggesting the presence 
of effective mechanisms of periph-
eral tolerance. Indeed, TRP1-specific 
T cells developing in the absence of 
GILT are characterized by an impaired 
capacity to produce IL-2 and IFN-γ 
upon specific or nonspecific stimula-
tion. This concept was explained by the 
fourfold increase in TRP1-specific Tregs 
in GILT-deficient mice compared with 
that of TRP1-deficient animals. Indeed, 
depletion of Tregs partially restored the 
ability of GILT-deficient TRP1-specific 
CD4+ T cells to induce vitiligo when 
transferred to RAG−/− mice.
Tregs are critical in maintaining self-
tolerance and immune homeostasis, 
and their development and function 
depend on the expression of the tran-
scription factor FoxP3. CD4+FoxP3+ 
T cells are functionally and pheno-
typically heterogeneous, providing 
plasticity to immune activation and 
regulation. Deletion of or mutations in 
the FOXP3 gene lead to severe auto-
immune disease in both humans and 
mice caused by alteration or disruption 
of Treg function.
The exact process of Treg selection 
is not fully understood, but it appears 
to be determined by the affinity of the 
interaction with the peptide–major 
histo compatibility complex (MHC) com-
plex: a T cell that receives strong signals 
will undergo apoptotic death; a cell that 
receives weak signals will survive and 
be selected to become an effector cell 
(Moon et al., 2011; Moran et al., 2011). 
If a T cell receives an inter mediate 
signal, then it will become a Treg. In 
addition, the overall avidity of the inter-
action between self-reactive thymocytes 
and their cognate self-peptide–MHC 
complexes may also direct T-cell fate. 
In the model system used by Rausch 
and Hastings (2012), the number of 
TRP1 peptide–MHC complexes is prob-
ably reduced in the absence of GILT. 
Therefore, the absence of GILT reduces 
the avidity of TCR interaction with 
peptide–MHC complexes and shifts the 
fate of TRP1-specific thymocytes from 
central deletion to Treg development.
Rausch and Hastings (2012) dem-
onstrate that GILT plays a critical 
role in regulating peripheral CD4+ 
T-cell tolerance to an endogenous 
skin-restricted antigen relevant to 
controlling autoimmunity. However, 
additional work is required to expand 
our knowledge of GILT and its func-
tion during the induction and main-
tenance of peripheral tolerance. The 
results of such studies may contribute 
to answering the question of wheth-
er GILT’s striking ability to control 
immune responses to melanocyte 
differentiation antigens might be 
harnessed for melanoma therapy—a 
notion that has already been explored 
in vitro and is supported by in vivo 
observations in patients with melano-
ma (Goldstein et al., 2008; Becker et 
al., 1999; Delfino et al., 2011).
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|GILT has the  potential to shape  CD4+ T-cell tolerance  
to self-antigens.
